4.6 Article

Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework

Related references

Note: Only part of the references are listed.
Article Immunology

Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom

Karina Doris Vihta et al.

Summary: A UK community study found that loss of taste/smell was less common in Omicron BA.1/BA.2 infections compared to Delta severe acute respiratory syndrome coronavirus 2 infections. There were smaller declines in reported shortness of breath, myalgia, and fatigue/weakness, but increases in sore throat, challenging symptom-based testing algorithms.

CLINICAL INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia

Marianna Zazhytska et al.

Summary: SARS-CoV-2 infection causes downregulation of olfactory receptors and their signaling components, offering insights into its effects on olfaction and other systems.
Article Genetics & Heredity

The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste

Janie F. Shelton et al.

Summary: Multi-ancestry genome-wide analyses have identified variants near UGT2A1 and UGT2A2 genes that are associated with COVID-19-related loss of smell or taste. These genes are expressed in the olfactory epithelium and play a role in metabolizing odorants.

NATURE GENETICS (2022)

Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Clinical Neurology

One-year cognitive follow-up of COVID-19 hospitalized patients

Roberta Ferrucci et al.

Summary: Cognitive impairment can still be observed after 1 year of recovery from COVID-19, with processing speed and long-term visuospatial and verbal memory being the most affected domains. Lower PaO2/FiO(2) ratios in the acute phase are associated with worse verbal long-term memory and visuospatial learning at 5 months. Recovered patients should receive periodic cognitive follow-up evaluations.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Editorial Material Immunology

Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019

Rafal Butowt et al.

Summary: The omicron variant of SARS-CoV-2 causes lower prevalence of anosmia compared to previous variants, possibly due to changes in tissue infection mechanisms. The new mutations make omicron less capable of infecting olfactory cells, thereby sparing olfactory function.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Otorhinolaryngology

Comparison of Olfactory Cleft Width and Volumes in Patients with COVID-19 Anosmia and COVID-19 Cases Without Anosmia

Deniz Esin Tekcan Sanli et al.

Summary: This study aimed to evaluate the relationship between olfactory cleft width/volume and COVID-19-related anosmia. Patients with COVID-19-related anosmia had larger olfactory cleft width and volumes compared to those without anosmia. The total TDI score showed an inverse correlation with cleft width and volume.

ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY (2022)

Article Biochemistry & Molecular Biology

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

Ben Killingley et al.

Summary: This study establishes a new SARS-CoV-2 human challenge model and investigates the viral kinetics during primary infection. The findings have implications for public health recommendations and strategies to control the transmission of SARS-CoV-2.

NATURE MEDICINE (2022)

Editorial Material Otorhinolaryngology

Differential olfactory outcomes in COVID-19: A large healthcare system population study

Nikita Chapurin et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Otorhinolaryngology

Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant

Paolo Boscolo-Rizzo et al.

Summary: The prevalence and severity of COVID-19-associated smell and taste dysfunction has significantly decreased with the advent of the Omicron variant but it still remains above 30%.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Allergy

Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)

Ludger Klimek et al.

Summary: Olfactory dysfunction is common in COVID-19, and sudden-onset dysosmia is an early marker for wild-type SARS-CoV-2 infection. A telemedicine-based study compared patients with VOC-Delta or wild-type SARS-CoV-2 infection, showing a significant decrease in olfactory function in both cohorts. VOC-Delta patients had higher olfaction scores at onset of illness and stronger odds of recovery at 4 weeks follow-up compared to WT patients.

WORLD ALLERGY ORGANIZATION JOURNAL (2022)

Article Medicine, General & Internal

Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection?

Juan Jose Rodriguez-Sevilla et al.

Summary: COVID-19 caused by SARS-CoV-2 has become a global public health concern. Hyposmia and anosmia have emerged as characteristic symptoms during the onset of the pandemic. The new Omicron variant has shown lower incidence of anosmia, potentially due to changes in viral proteins or previous immunity.

FRONTIERS IN MEDICINE (2022)

Review Neurosciences

Pathogenesis of Olfactory Disorders in COVID-19

Laura Ziuzia-Januszewska et al.

Summary: This review summarizes the current understanding of the pathogenesis of smell impairment in COVID-19 and suggests potential avenues for future research. Multiple theories have been proposed, including sensorineural damage, infection of olfactory epithelium support cells, and disruption of olfactory pathways. However, the exact mechanisms are still not fully elucidated and require further investigation.

BRAIN SCIENCES (2022)

Review Biochemistry & Molecular Biology

SARS-CoV-2 cell entry beyond the ACE2 receptor

Shamila D. Alipoor et al.

Summary: The infectivity of SARS-CoV-2 is likely due to its ability to utilize a group of cell surface receptors, including ACE2, as entry sites. However, there may be other receptors and auxiliary membrane proteins involved in the cell entry process. The presence of these receptors may explain certain characteristics of COVID-19 infections, such as asymptomatic hypoxemia. Different variants of SARS-CoV-2 may exhibit varying degrees of binding affinity to these receptors.

MOLECULAR BIOLOGY REPORTS (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters

Federico Armando et al.

Summary: This study compares virus spread and pathology in Syrian golden hamsters infected with different variants of SARS-CoV-2 and finds that the Omicron variant causes milder pathology.

NATURE COMMUNICATIONS (2022)

Article Medicine, General & Internal

Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves

Benjamin Kye Jyn Tan et al.

Summary: This study aims to investigate the recovery rate of smell and taste in patients with COVID-19, the proportion of patients with persistent dysfunction, and the prognostic factors associated with recovery. The findings suggest that a substantial proportion of patients may experience long-term changes in their sense of smell or taste, contributing to the burden of long COVID.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Review Medicine, General & Internal

Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework

Laure-Alix Clerbaux et al.

Summary: This article utilizes the Adverse Outcome Pathway (AOP) framework to describe how eleven selected factors influence COVID-19 and its underlying mechanisms. The approach helps identify knowledge gaps for further research and proposes biomarkers for high-risk patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Infectious Diseases

First cases of Omicron in France are exhibiting mild symptoms, November 2021-January 2022

A. Maisa et al.

Summary: This study investigated the first cases of Omicron detected in France and found that most cases presented with mild symptoms, including young individuals and those who were vaccinated. The findings provide important support for the national COVID-19 surveillance system.

INFECTIOUS DISEASES NOW (2022)

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of Hamsters

Anna Jinxia Zhang et al.

Summary: COVID-19 primarily affects the respiratory tract but can also lead to olfactory dysfunction, particularly in young patients. In a study using Syrian hamsters, it was found that SARS-CoV-2 infection could impact mature and immature olfactory neurons and supporting cells, potentially contributing to the olfactory dysfunction seen in COVID-19 patients.

CLINICAL INFECTIOUS DISEASES (2021)

Article Clinical Neurology

Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection

Rafal Butowt et al.

Summary: The prevalence of smell and taste dysfunction in COVID-19 differs between populations, possibly due to differences in virus strains or host proteins. Recent progress has been made in defining the cellular and molecular mechanisms of virus-induced anosmia, focusing on the role of sustentacular cells in the olfactory epithelium. The potential for using smell and taste dysfunctions as early diagnostic tools in COVID-19 is discussed.

NEUROSCIENTIST (2021)

Article Anatomy & Morphology

Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb

Moritz Klingenstein et al.

Summary: The study reveals the expression of ACE2 and TMPRSS2 proteins in the human nose, olfactory epithelium, and olfactory bulb, providing essential anatomical evidence for future research on SARS-CoV2-induced anosmia through the olfactory pathway.

CELLS TISSUES ORGANS (2021)

Article Biochemistry & Molecular Biology

Article Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb

Mona Khan et al.

Summary: Anosmia, the loss of smell, is a common symptom of COVID-19, but it is caused by the virus attacking sustentacular cells in the olfactory mucosa rather than infecting olfactory sensory neurons. This suggests that SARS-CoV-2 is not a neurotropic virus.
Article Medicine, Research & Experimental

Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients

Jeyasakthy Saniasiaya et al.

Summary: A systematic review and meta-analysis found that the overall prevalence of olfactory dysfunction in COVID-19 patients is 47.85%, with European patients having the highest prevalence and Asian patients the lowest. Discrepancies between objective and subjective evaluations suggest further studies are needed.

LARYNGOSCOPE (2021)

Article Neurosciences

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Jenny Meinhardt et al.

Summary: The study demonstrates the presence of SARS-CoV-2 in the nasopharynx and brain, suggesting the virus may enter the CNS through the olfactory mucosa. The virus utilizes the neural-mucosal interface in the olfactory mucosa to penetrate the nervous system, affecting various neuroanatomical areas, including the primary respiratory and cardiovascular control center.

NATURE NEUROSCIENCE (2021)

Editorial Material Clinical Neurology

Neurological infection with SARS-CoV-2-the story so far

Tom Solomon

NATURE REVIEWS NEUROLOGY (2021)

Review Microbiology

The role of Neuropilin-1 in COVID-19

Bindu S. Mayi et al.

Summary: NRP-1, a member of a family of signaling proteins, plays a critical role in SARS-CoV-2 infection and may be involved in immune function, transmission pathways, and disease severity. Research suggests NRP-1 could serve as a therapeutic target in SARS-CoV-2 infections, highlighting the need for further study.

PLOS PATHOGENS (2021)

Review Microbiology

Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity

Deepmala Karmakar et al.

Summary: SARS-CoV-2, a novel coronavirus identified in Wuhan, China in December 2019, has led to the global pandemic of COVID-19. While 80% of patients show mild symptoms, the disease can progress to affect major organs in severe cases due to immune system imbalance.

PATHOGENS (2021)

Article Biochemistry & Molecular Biology

Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters

Shinji Urata et al.

Summary: Olfactory dysfunction is a common symptom of COVID-19, but the damage and repair of the neuroepithelium after SARS-CoV-2 infection is still incomplete. In a study using golden Syrian hamsters, severe damage was observed in the olfactory epithelium post-inoculation, with the nasal septal region showing faster recovery. This suggests that anosmia related to SARS-CoV-2 infection may be fully reversible.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Koen B. Pouwels et al.

Summary: A large, community-based study in the United Kingdom indicates that the effectiveness of BNT162b2 and ChAdOx1 vaccines against SARS-CoV-2 infections with symptoms or high viral burden is reduced with the Delta variant compared to the Alpha variant. Although the effectiveness of two doses is at least as great as protection afforded by prior natural infection, there are significant differences in the dynamics of immunity after the second dose between BNT162b2 and ChAdOx1.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics

Christoph Muus et al.

Summary: Our study reveals that cell-type-specific expression patterns of ACE2, TMPRSS2, and CTSL are associated with the pathogenesis of COVID-19. Factors such as age, sex, and smoking status are linked to the expression of viral entry genes in respiratory cell populations, suggesting potential therapeutic targets for intervention. The integrated analysis of single-cell and single-nucleus transcriptomics studies highlights coexpression patterns of SARS-CoV-2 viral entry genes across different human tissues.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation

Steven Andrew Baker et al.

Summary: The study found that ACE2 expression increases with age in patients on mechanical ventilation, particularly in the presence of alveolar damage. This could be a potential mechanism for higher Covid-19 mortality in the elderly.

PLOS ONE (2021)

Review Neurosciences

A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants

Maria Tsamou et al.

Summary: The prevalence of sporadic Alzheimer's disease is increasing worldwide, with aging and genetics playing important roles but systemic and environmental factors also contributing. The Adverse Outcome Pathway concept has potential to enhance understanding and research in human disease.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Cell Biology

COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters

Guilherme Dias de Melo et al.

Summary: Recent investigations have shown that olfactory and taste dysfunction are common in mildly symptomatic COVID-19 patients. Research on the olfactory neuroepithelium revealed that SARS-CoV-2 infection can cause local inflammation and lead to acute loss of smell, which may account for prolonged symptoms of COVID-19 such as anosmia.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Public, Environmental & Occupational Health

Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework

Penny Nymark et al.

Summary: Adverse Outcome Pathways (AOP) offer structured frameworks for organizing research data and knowledge systematically across disciplines related to human health. The COVID-19 pandemic has attracted worldwide scientific engagement, leading to the initiation of projects like CIAO to develop AOPs for COVID-19, aiming to improve interpretation and efficient application of scientific understanding on the pandemic.

FRONTIERS IN PUBLIC HEALTH (2021)

Review Biochemistry & Molecular Biology

The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia

Christopher S. von Bartheld et al.

Summary: The prevalence of chemosensory dysfunction in COVID-19 patients varies greatly between populations, possibly due to factors at the host and virus levels. The D614G mutation is identified as a major contributing factor to the increased prevalence of anosmia in COVID-19.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

Mapping the human genetic architecture of COVID-19

Mari E. K. Niemi et al.

Summary: The genetic make-up of an individual plays a role in susceptibility and response to viral infections. A global network of researchers identified 13 significant genetic loci associated with SARS-CoV-2 infection and severe COVID-19 cases. Mendelian randomization analyses suggest a causal role for smoking and body-mass index in severe COVID-19. Collaboration among human genetics researchers has allowed for the discovery of novel host genetic factors linked to COVID-19.

NATURE (2021)

Article Cell Biology

SARS-CoV-2 infection in the mouse olfactory system

Qing Ye et al.

Summary: The study reveals that SARS-CoV-2 infection causes olfactory dysfunction, with its mechanism unclear, but replicable in a mouse model and providing critical clues to understanding extrapulmonary manifestations of COVID-19. These findings suggest a direct impact on olfactory structures and gene expression, triggering immune responses and cell death.

CELL DISCOVERY (2021)

Editorial Material Biochemistry & Molecular Biology

Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms

Abdul Mannan Baig et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Letter Otorhinolaryngology

Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19

Michael Eliezer et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Article Multidisciplinary Sciences

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sin Fun Sia et al.

NATURE (2020)

Review Behavioral Sciences

Anosmia in COVID-19: Mechanisms and Significance

Albert Y. Han et al.

CHEMICAL SENSES (2020)

Review Biochemistry & Molecular Biology

Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences

Christopher S. von Bartheld et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Article Neurosciences

Ageusia and anosmia, a common sign of COVID-19? A case series from four countries

Jair Vargas-Gandica et al.

JOURNAL OF NEUROVIROLOGY (2020)

Letter Otorhinolaryngology

Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?

Simon B. Gane et al.

RHINOLOGY (2020)

Review Otorhinolaryngology

Olfactory and taste disorders in COVID-19: a systematic review

Klinger V. T. da Costa et al.

BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY (2020)

Article Multidisciplinary Sciences

Neuropilin-1 is a host factor for SARS-CoV-2 infection

James L. Daly et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Ludovico Cantuti-Castelvetri et al.

SCIENCE (2020)

Review Clinical Neurology

Central Nervous System Manifestations Associated with COVID-19

Afshin A. Divani et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)

Article Medicine, General & Internal

Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients

Yonghyun Lee et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Review Otorhinolaryngology

Olfactory Epithelium: Cells, Clinical Disorders, and Insights from an Adult Stem Cell Niche

Rhea Choi et al.

LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2018)

Review Neurosciences

Stem and progenitor cells of the mammalian olfactory epithelium: Taking poietic license

James E. Schwob et al.

JOURNAL OF COMPARATIVE NEUROLOGY (2017)

Article Multidisciplinary Sciences

Notch1 maintains dormancy of olfactory horizontal basal cells, a reserve neural stem cell

Daniel B. Herrick et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Cell & Tissue Engineering

Deconstructing Olfactory Stem Cell Trajectories at Single-Cell Resolution

Russell B. Fletcher et al.

CELL STEM CELL (2017)

Article Medicine, Legal

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)

Knut Erik Tollefsen et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)

Review Neurosciences

A lifetime of neurogenesis in the olfactory system

Jessica H. Brann et al.

FRONTIERS IN NEUROSCIENCE (2014)

Article Anatomy & Morphology

Odorant-Binding Proteins and Xenobiotic Metabolizing Enzymes: Implications in Olfactory Perireceptor Events

Jean-Marie Heydel et al.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2013)

Review Biochemistry & Molecular Biology

Encoding olfactory signals via multiple chemosensory systems

Minghong Ma

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)

Article Multidisciplinary Sciences

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

H Hofmann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Neurosciences

Ionic conductances in sustentacular cells of the mouse olfactory epithelium

F Vogalis et al.

JOURNAL OF PHYSIOLOGY-LONDON (2005)